Monitor for the filing of the S-4 registration statement and proxy statement, which will provide detailed deal terms and voting timeline. The stock is likely to trade near the implied deal value until closing, with the spread reflecting regulatory and timing risk.
Price Chart
Executive Summary
Sanara MedTech filed a routine 425 communication (LinkedIn post) reiterating the previously announced definitive agreement to be acquired by MiMedx Group for approximately $350 million ($33.00 cash + 0.4735 MiMedx shares per SMTI share). The filing contains no new financial terms, revised synergy estimates, or regulatory updates, and is purely promotional stakeholder reassurance.
Key Financial Metrics
Key Facts
- Filing is a LinkedIn post from July 29, 2026, confirming the pending acquisition by MiMedx Group.
- Deal valued at approximately $350 million, or $35 per share ($33.00 cash + 0.4735 MiMedx shares).
- Transaction expected to close by end of year, subject to shareholder approval, regulatory approvals, and customary conditions.
- No new financial data, guidance, or deal terms disclosed beyond the initial announcement.
Financial Impact
No new financial impact; deal terms unchanged from prior announcement.
Risk Factors
- Shareholder approval not guaranteed.
- Regulatory approval delays or denial.
- Termination fee or deal failure risk.
- Market price of MiMedx shares affects the stock component of consideration.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (SMTI) — Batch item 1 | 0001493152-26-035419 |
| Document: 0001493152-26-035419-index-headers.html | 0001493152-26-035419 |
| Document: 0001493152-26-035419.txt | 0001493152-26-035419 |
| 425 Filing (SMTI) — Batch item 4 | 0001493152-26-035419 |
| Document: 0001493152-26-035419-index-headers.html | 0001493152-26-035419 |
| Document: 0001493152-26-035419.txt | 0001493152-26-035419 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 425 | $33.16 $32.80 | ▲ +1.09% | ▲ +1.18% | $32.84 (+0.97%) |
Oct 16, 2026 11d ago | 8-K | $33.16 $32.80 | ▼ −1.09% | ▼ −1.18% | $32.84 (−0.97%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jun 4, 2026 20w ago | 8-K | $22.44 $20.81 | ▼ −7.26% | ▼ −7.83% | $32.84 (+46.35%) |
May 11, 2026 24w ago | 8-K | $20.44 $21.89 | ▲ +7.09% | ▲ +7.02% | $32.84 (+60.67%) |
Apr 17, 2026 27w ago | DEFA14A | $20.62 $18.93 | ▼ −8.20% | ▼ −9.11% | $32.84 (+59.26%) |
Apr 17, 2026 27w ago | DEFA14A | $20.77 $19.22 | ▼ −7.46% | ▼ −8.02% | $32.84 (+58.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers